Investing Profile

Steven St. Peter

InvestorVC
Managing Director at JDRF T1D Fund
Photo of Steven St. Peter, Managing Director at T1D Fund
cb
T1D Fund Managing Director
$100K - $5.0M
$1.5M
7
CompanyStageDateRound SizeTotal Raised
vTv Therapeutics
Post Ipo EquityFeb 2024$51M
$51M
Aratana Therapeutics
Series BDec 2011$15M
Series AJan 2011$20M
$35M
Co-investors: Jay Lichter (Avalon Ventures), Ron Meeusen (Cultivian Sandbox Ventures)
Syndax Pharmaceuticals
Series AMar 2010$9M
Series AApr 2007$40M
$180M
Co-investors: Dennis Podlesak (Domain Associates), Kim P. Kamdar (Domain Associates)
Rhythm Pharmaceuticals
Series AMar 2010$40M
$110M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Barbara Dalton (Pfizer Venture Investments)
EKR Therapeutics
Series DMar 2008$50M
$50M
Founder and Managing Director Vie Ventures2012 - Present